Shilpa Medicare announces receipt of CEP from EDQM for API 'Desmopressin'

Shilpa Medicare's 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for API, Desmopressin.